Ipsen SA - Company Profile
Powered by
All the data and insights you need on Ipsen SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Ipsen SA Strategy Report
- Understand Ipsen SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Ipsen SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
01 Aug 2022 | Ipsen and Marengo Therapeutics Enter into Agreement | Partnership | - |
Ipsen SA
Marengo Therapeutics Inc
|
27 Jun 2022 | Ipsen Acquires Epizyme | Acquisition |
Ipsen SA
|
Epizyme Inc |
04 Apr 2022 | SERB Acquires Rights of Xermelo from Ipsen | Asset Transaction |
Serb SA
|
Ipsen SA |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer